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Relative hypoxia has been shown to develop in white adipose tissue depots of different
types of obese mouse (genetic, dietary), and this leads to substantial changes in white
adipocyte function. These changes include increased production of inflammation-related
adipokines (such as IL-6, leptin, Angptl4, and VEGF), an increase in glucose utilization and
lactate production, and the induction of fibrosis and insulin resistance. Whether hypoxia
also occurs in brown adipose tissue depots in obesity has been little considered. However,
a recent study has reported low pO2 in brown fat of obese mice, this involving mito-
chondrial loss and dysfunction. We suggest that obesity-linked hypoxia may lead to similar
alterations in brown adipocytes as in white fat cells – particularly changes in adipokine pro-
duction, increased glucose uptake and lactate release, and insulin resistance. This would
be expected to compromise thermogenic activity and the role of brown fat in glucose
homeostasis and triglyceride clearance, underpinning the development of the metabolic
syndrome. Hypoxia-induced augmentation of lactate production may also stimulate the
“browning” of white fat depots through recruitment of UCP1 and the development of
brite adipocytes.
Keywords: adipocyte, brite cell, brown adipose tissue, hypoxia, lactate, uncoupling protein-1, oxygen,white adipose
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INTRODUCTION
Oxygen is rarely considered as an essential nutrient in mammals
and this is primarily because it is delivered through the lungs
rather than in the diet via the gastrointestinal tract. However,
at a cellular level, it is a key nutritional factor without which
oxidative metabolism – particularly oxidative phosphorylation in
mitochondria – cannot take place. The delivery of O2 to cells from
the circulation is via a specific carrier protein, hemoglobin, paral-
leling the general mechanism by which a number of nutrients are
delivered. At a whole-body level, the consequences of, and adap-
tations to, low O2 tension have been extensively investigated. This
is especially so in relation to high altitude and in response to the
O2 deprivation experienced during deep-sea diving. The effect of
a lack of O2 has also been widely considered in relation to disor-
ders such as obstructive pulmonary disease where lung function
is impaired, and during the periodic reduction in O2 delivery in
sleep apnea (1).
These states impact on the provision of O2 to the body as
a whole. Changes in O2 level in individual tissues, specifically a
reduction, can occur even when the total supply is not compro-
mised. Examples include at the site of wounds during healing from
tissue damage, and in the center of solid tumors (2–4). There is
growing recognition that low O2 tension, indeed overt hypoxia, can
occur in tissues with important implications for cellular function.
White adipose tissue (WAT) is one site where hypoxia has been
demonstrated and this occurs with the expansion of adipocyte
size and total adipose mass in obesity (5–8).
In this article, we provide a perspective on the effects of hypoxia
on the function of white adipocytes and consider, in particular,
whether hypoxia also occurs in brown adipose tissue (BAT). It
has been argued, of course, that collectively white and brown
fat constitute a single adipose organ (9). We speculate on the
effects that reduced O2 tension might have on the function of
brown adipocytes and the possible implications for obesity and
the metabolic syndrome.
WHITE ADIPOSE TISSUE
White adipose tissue, which is a major component of total
body composition comprising at least 40% of body weight
in obese adults, is the principal site of fuel storage and
has major additional functions including in particular that of
being a key endocrine organ. White adipocytes, the signa-
ture cell of WAT, are major secretory cells, releasing a mul-
tiplicity of lipid and protein moieties additional to the fatty
acids mobilized by lipolysis (8, 10). Several pleiotropic pro-
tein hormones are synthesized and secreted by white adipocytes,
the most prominent being leptin and adiponectin (11, 12).
These hormones were first discovered in adipose tissue, and the
identification of leptin firmly established white adipocytes as
endocrine cells.
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Subsequent investigations demonstrated that white fat cells
secrete a large and diverse range of “adipokines” (13–16), with
proteomic studies suggesting that there are several hundred
such protein factors (17). Multiple adipokines are associated
with inflammation, including classical cytokines and chemokines
such as TNFα, IL-1β, IL-6, and MCP-1 (13–15). The synthe-
sis and release of a number of inflammation-related adipokines
increase in obesity, adipose tissue depots becoming “inflamed”
with the inflammatory state underpinning the development of
obesity-associated diseases – particularly insulin resistance and
the metabolic syndrome (10, 15, 18, 19).
Adipokines are not the only inflammation-related moieties
produced by white adipocytes, various prostaglandins also being
released (8). These lipid factors have received much less atten-
tion in considering the inflammatory response in adipose tissue.
Indeed, there has been markedly less focus overall on the lipid
secretions from the tissue – apart from fatty acids. This is despite
white adipocytes releasing multiple lipid moieties, which include
endocannabinoids (such as anandamide), cortisol (by the conver-
sion of cortisone), vitamin D3, vitamin A, and cholesterol – some
of which are sequestered within WAT rather than being synthesized
de novo (1, 8).
HYPOXIA IN WHITE ADIPOSE TISSUE
Hypoxia is one of the central mechanisms postulated to explain
the development of inflammation and the subsequent metabolic
dysfunction of WAT in obesity (10, 20, 21). This is linked to the
growing recognition that O2 levels are far from the same in all tis-
sues, and neither are they constant. For example, while the general
level of tissue oxygenation (pO2) is 45–50 mmHg, that of the thy-
mus is 10 mmHg, while for the brain it is as low as 0.4–8 mmHg (3,
22) – and the center of solid tumors can be essentially anoxic (2, 3).
In the case of WAT, it was proposed that as fat mass expands in the
obese, large adipocytes become distant from the vasculature and
areas of O2 deprivation occur (10, 20). Hypoxia was subsequently
demonstrated in WAT in various obese rodents – genetically obese
ob/ob and KKAy mice, and mice with diet-induced obesity (5–
7). Two distinct experimental approaches documented hypoxia
in these obese mice; in one, which utilized the hypoxia marker
pimonidazole, low pO2 was shown qualitatively. Quantitative mea-
surements have been obtained using needle-type O2 sensors, and
these found between 2- and 3.5-fold reductions in pO2 in WAT
of ob/ob and dietary obese mice relative to lean controls – down
to 15 mmHg compared with 45–50 mmHg, for obese and lean
animals, respectively (5–7, 23).
In contrast to the clear evidence for hypoxia in WAT in rodent
obesity, the situation in obese humans is more problematic. Sev-
eral earlier studies demonstrated reduced pO2 in human obesity,
consistent with the more limited vascularization in the obese –
limited since the blood supply to WAT does not rise despite the
substantial increase in the size of the fat depots (24–26). Propor-
tionally, the vascular supply is reduced per unit adipose mass in
obese humans, capillary density being lower than in the lean. A
further key observation is that obese humans do not exhibit the
post-prandial rise in blood flow to WAT that occurs in lean indi-
viduals (27, 28). While the degree of hypoxia is the modest in the
human studies recording reduced O2 tension, two recent reports
have found no evidence for lower O2 levels (28, 29). Indeed, in one
study, hyperoxia rather than hypoxia was noted (28). In the study
reporting neither hypoxia nor hyperoxia, reduced delivery of blood
and lowered consumption of O2 were observed, nevertheless; in
addition, there was a net release of lactate, consistent with anaero-
bic glycolysis (29). At present, it is not evident why such divergent
results have been obtained, although methodological issues may
be important.
In parallel with in vivo investigations on the O2 tension of
WAT in obesity, extensive in vitro studies on the molecular and
cellular response to hypoxia of adipocytes (human and rodent)
in culture have been undertaken (5, 6, 8, 30–32). These ini-
tially focused on the expression (and in some cases release) of
key adipokines, both those directly linked to inflammation and
the signature adipocyte hormones leptin and adiponectin. The
expression and release of leptin, VEGF, serum amyloid A, Angptl4,
and IL-6, for example, are increased in the presence of hypoxia,
while adiponectin production is reduced (5, 6, 8, 30–32). This is
indicative of the induction of an inflammatory state. Microar-
ray studies have shown that the expression of up to 1,300 genes
is hypoxia-sensitive (~50% upregulated/~50% downregulated) in
human adipocytes, indicating an extensive effect of low O2 ten-
sion on gene expression in these cells (33, 34). The genes encoding
proteins in key pathways and processes modulated by low pO2
include those associated with glycolysis, mitochondrial (oxida-
tive) metabolism, cell death, and inflammation (33, 34). Some
of these changes clearly reflect a switch from aerobic to anaerobic
metabolism.
Alterations in gene expression in hypoxia, not all of which are
necessarily primary, are, of course, significant, but it is changes in
metabolic function that are of greatest importance. Studies with 2-
deoxy-d-glucose demonstrate that glucose uptake into adipocytes
is stimulated by hypoxia, and this is a transport-mediated process
(35, 36). The key transporter involved is GLUT1, responsible for
basal glucose uptake in many cells, since hypoxia induces a sub-
stantial increase in its expression and amount (35, 37). There is a
parallel elevation in the release of lactate from hypoxic adipocytes,
this also involving the recruitment of a specific transport pro-
tein – MCT1, a monocarboxylate transporter (38). Increases in
glucose uptake and lactate release are indicative of the stimulation
of anaerobic glycolysis and the levels of glycolytic enzymes, as well
as the expression of genes linked to glycolysis, are raised in hypoxic
adipocytes (33, 34, 39).
Other functional changes in fat cells in response to low pO2
include the rates of lipolysis and lipogenesis. Lipolysis is reported
as both increased and unchanged; however, the evidence for the
former appears stronger (23, 30, 40). Lipogenesis is reduced in
hypoxia, as is the uptake of fatty acids, and the effect of reduced
pO2 on these processes may be mediated through an inhibition of
hexosamine biosynthesis (23, 40). A major direct effect of hypoxia
on adipocyte function is the induction of insulin resistance. Thus,
there is a loss of insulin-stimulated glucose uptake, as indicated
by 2-deoxy-d-glucose studies, and an inhibition of the insulin sig-
naling pathway – including a lack of phosphorylation of insulin
receptor-β and insulin receptor substrate (23, 36). Insulin resis-
tance may well be the key element in adipose tissue dysfunction
induced by hypoxia in obesity.
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A further area of adipocyte function in which low O2 tension
plays a role is in the induction of a pro-fibrotic transcriptional
program, fibrosis resulting from the disruption of the extracellular
matrix (41, 42). Fibrosis is now considered as part of adipose tissue
dysfunction in obesity, and the expression of a number of genes
encoding proteins of the extracellular matrix, including specific
collagens, is altered in adipocytes by hypoxia (42).
Other cells in WAT additional to adipocytes are sensitive to
hypoxia, including macrophages and pre-adipocytes. In the case of
macrophages, the inflammatory state is stimulated by low pO2 (6,
43, 44). A major effect of hypoxia on pre-adipocytes is to inhibit
the differentiation of these precursor cells into adipocytes, this
involving a downregulation of PPARγ through the key hypoxia-
inducible transcription factor, HIF-1 (8). A particularly intrigu-
ing effect of low pO2 on pre-adipocytes is their conversion into
leptin-secreting, endocrine cells; prior to their differentiation into
mature adipocytes, pre-adipocytes do not express the Lep gene
(45). This effect is evident with overt hypoxia (1% O2) and an
important question is at what O2 level pre-adipocytes express the
Lep gene and secrete functional leptin. It has been argued that
the lack of leptin production by pre-adipocytes cultured under
normal conditions may be an artifact, reflecting an inhibitory
effect of hyperoxia since the cells are customarily incubated under
21% O2 (1).
This raises the broader question of the appropriate O2 ten-
sion at which to culture or incubate cells in general. Again, the
21% O2 present in air is usually employed, but this represents
a considerably higher O2 tension than the 45–50 mmHg (~7%
O2 equivalent) that most tissues normally experience. A study on
human adipocytes exposed to different levels of O2 indicates that
at physiological levels of oxygenation the cells exhibit increased
expression of those adipokine genes that are hypoxia-sensitive and
there is elevated secretion of the functional protein relative to 21%
O2 (37). Similarly, glucose uptake and lactate release, together with
the expression of their respective transporters, are greater at 7% O2
than at so-called “normoxia” (37). Thus, at physiological levels of
O2 adipocytes (and other cells) are relatively hypoxic and exhibit
some of the cellular changes characteristic of this state – though
greater effects are evident with 1% O2.
BROWN ADIPOSE TISSUE
There has been little consideration of whether hypoxia occurs in
BAT in obesity, and if so whether the key functions of brown
adipocytes are modified. The primary role of BAT as a special-
ized organ for generating heat by non-shivering mechanisms (46,
47) is dependent on the extensive vascularization that is evident
in the tissue. A substantial blood supply is required to provide O2
and other nutrients to fuel thermogenesis and to rapidly distribute
heat throughout the body – in part, to ensure that BAT is not itself
damaged through an inappropriate elevation in local temperature.
Heat constitutes, of course, the primary form of cross-talk from
BAT to other tissues.
Heat is generated in brown adipocytes through the uncou-
pling of oxidative phosphorylation such that the proton gradient
across the inner mitochondrial membrane is dissipated as heat
rather than being coupled to ATP synthesis (47, 48). This pro-
ton conductance pathway is dependent on, and regulated by, the
32,000 mol. wt. mitochondrial uncoupling protein, UCP1 (49, 50).
Thermogenesis is stimulated by noradrenaline released from the
sympathetic nervous system, with the sympathetic system also
playing a central role in the development of thermogenic capacity
(51). By virtue of its role in heat production for thermoregula-
tion, BAT is prominent in small rodents adapted to the cold, in the
newborn of precocial species (such as lambs and cattle), and in
hibernators (such as ground squirrels). BAT is also a site of diet-
induced thermogenesis with this form of adaptive heat production
being a component in the regulation of energy balance and body
fat (52–54). Throughout the 1980s, BAT was a key focus of obesity
research, reflecting the proposition that reduced thermogenesis is
important in the etiology of the obese state (54–56).
The recent renewed interest in BAT has followed from reports
in which definitive evidence for metabolically active brown fat
in adult humans has been presented. The application of fluo-
rodeoxyglucose positron emission tomography (FDG-PET) has
identified sites of fat tissue that exhibit high glucose uptake (57),
and together with immunostaining for UCP1 has unambiguously
identified BAT in adult humans (58–60). Subsequent reports have
demonstrated that the abundance and thermogenic activity of
brown fat in humans exhibits considerable plasticity, FDG-PET
investigations indicating that acute exposure to cold activates BAT
in humans (59, 61–63). Importantly, in relation to energy balance,
observations from FDG-PET indicate an inverse relationship of
BAT activity to age and BMI, the tissue being less active, or less
evident, in older subjects and in the obese (64–66).
While the central role of BAT is to generate heat, brown
adipocytes produce and secrete specific protein signals – in effect
adipokines similar to white fat – and these include leptin and IL-6
(67–69). The actions of these adipokines is likely to be essentially
autocrine/paracrine, rather than endocrine, since the contribution
from brown fat to circulating levels will be small relative to that of
WAT. Whether the “adipokinome” in brown adipocytes is exten-
sive is unknown. BAT is increasingly recognized to have direct
metabolic functions, FDG-PET studies showing that the tissue has
a high rate of glucose uptake, which can be stimulated by insulin
as well as cold exposure (59, 61–63). Recent reports have demon-
strated that brown fat is important in glucose homeostasis with
the tissue being proposed as a major organ in glucose disposal and
insulin sensitivity (70, 71). A further metabolic role now attrib-
uted to the tissue is in triglyceride clearance, particularly during
cold exposure (70, 72).
An apparent substantive contribution of BAT to glucose home-
ostasis, insulin sensitivity and lipid clearance has led to the sug-
gestion that reduced activity of the tissue may be implicated in
the development of the metabolic syndrome, with re-activation
potentially leading to a reversal of the syndrome (72, 73).
HYPOXIA IN BROWN ADIPOSE TISSUE
As noted above, BAT is highly vascularized consistent with the need
to supply O2 and other nutrients to meet the metabolic demands
of thermogenesis. Studies on regional blood flow in the late 1970s
indicated that the tissue is responsible for >50% of total non-
shivering thermogenesis in rats acclimated to the cold, with up to
one-third of the total cardiac output being directed toward BAT
during maximal thermogenesis (74, 75). In the case of Sultzer’s
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vein, which drains the main interscapular depot in rodents, O2
extraction appears almost total (76).
Increased lipid deposition occurs in brown adipocytes in obe-
sity with BAT enlarging in obese animals, similar to the expansion
of white fat depots. The increase in adipocyte size in BAT raises
the possibility that pockets of reduced O2 tension develop in the
tissue in the obese and that this leads to the inhibition of the acute
thermogenic response. Indeed, hypoxia may have major effects on
gene expression and cellular metabolism in brown adipocytes, as in
white,BAT function being compromised through the development
of insulin resistance and reduced thermogenesis. BAT thermoge-
nesis is recognized to be reduced in obese rodents, as indicated
by measurements of regional blood flow and O2 utilization in
response to noradrenaline, as well as from studies on the amount
and activity of UCP1 (55, 56, 77).
Hypoxia has been observed through pimonidazole staining in
BAT of lean mice exposed to the cold (4°C), but it is not evident
in mice acclimated to the warm (30°C); Ucp1 knockout indicates
that it occurs only with thermogenic activity (78). A recent study
has directly examined whether there is hypoxia in brown fat in
the obese and described evidence for vascular “rarefaction” in BAT
of mice with diet-induced obesity, leading to a “whitening” of
the tissue with enlarged lipid droplets together with mitochondr-
ial dysfunction and loss (79). Hypoxia was demonstrated in the
obese by pimonidazole staining and with a fiber-optic O2 sensor,
the latter indicating a >5-fold reduction in pO2 compared with
BAT of lean mice – a greater degree of hypoxia than occurred in
WAT of the same animals. Among the other changes observed in
the obese BAT were increases in the level of the hypoxia-sensitive
transcription factor subunit, HIF-1α, and falls in Ucp1 expression
and β-adrenergic signaling (79).
By analogy with white adipocytes, there are a number of
other potential effects of hypoxia on brown adipocytes in obesity
(Figure 1). These include changes in the transcription of a range of
hypoxia-sensitive genes, including those encoding adipokines; the
expression of leptin, VEGF, and IL-6, for example, may increase.
Glucose uptake would be expected to rise through increased
expression and recruitment of GLUT1. Insulin-stimulated glucose
uptake, on the other hand, may fall through the development of
insulin resistance. A loss of insulin sensitivity is evident in BAT of
obese animals and occurs in ob/ob mice soon after weaning (80,
81). This development of resistance is associated with a reduction
in acute thermogenesis, and its reversal with ciglitazone restores
the thermogenic response of BAT to cold (82).
Further potential metabolic changes in brown adipocytes in
response to low O2 tension include the induction of fibrosis and
a fall in lipogenesis and fatty acid uptake. Reduced lipid uptake as
well as the induction of insulin resistance would be consistent with
hypoxia being a mechanism for the development of the metabolic
syndrome in obesity, given the postulated role of BAT in glucose
homeostasis and triglyceride clearance. This, together with direct
effects on limiting thermogenesis itself, suggests that hypoxia has
the potential to severely compromise BAT function with important
implication for metabolic homeostasis and disease processes.
If mitochondrial loss and dysfunction are induced in BAT by
hypoxia and glucose utilization is elevated, this would indicate a
switch to anaerobic glycolysis. One of the consequences of such
a switch would be an increase in lactate production and release,
FIGURE 1 | Schematic view of the potential effects of hypoxia on brown adipocyte function. FA, fatty acid; GLUT1, facilitative glucose transporter-1; HIF-1,
hypoxia-inducible factor-1; IL-6, interleukin-6; MCT1, monocarboxylate transporter-1; TFs, transcription factors; Ucp1, uncoupling protein-1 (gene); VEGF, vascular
endothelial growth factor.
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involving the further recruitment of the MCT1 transporter. Lac-
tate has recently emerged as an important metabolic signal, the
functions attributed to it including the stimulation of inflam-
mation in macrophages and – importantly – mediation of the
anti-lipolytic effect of insulin (83, 84). This anti-lipolytic action is
via the GPR81 receptor, which is expressed principally in adipose
tissues (84).
HYPOXIA AND THE RECRUITMENT OF BRITE ADIPOCYTES
A further major function recently identified for lactate is in the
“browning” of white adipocytes (85). The concept of browning
has emerged with the recognition that there is a third type of
adipocyte in addition to white and brown fat cells – the brite (or
beige) adipocyte. Brite cells are found especially in white fat depots
and have many, though not all, of the molecular characteristics of
brown adipocytes (86, 87). The key feature shared by brite and
brown adipocytes is the presence of UCP1, providing the potential
for thermogenesis (86, 88).
Cold exposure of mice results in an elevation in circulating lac-
tate levels and Mct1 gene expression is stimulated in both BAT and
WAT (85). Treatment with lactate, in vivo or in vitro, induces Ucp1
gene expression in white adipocytes and the expression of genes
associated with fatty acid oxidation and mitochondrial function,
indicative of the recruitment of a thermogenic profile (85). Lac-
tate does not lead to the induction of UCP1 in white fat cells
through the GPR81 receptor, but rather by modulation of MCT
activity; preventing lactate influx by pharmacological inhibition of
MCTs suppressed the lactate-induced expression of Ucp1. Corre-
spondingly, knockdown of MCT4, the transporter responsible for
lactate efflux, strongly enhanced Ucp1 expression in adipocytes. It
is suggested that the lactate-induced expression of Ucp1 in white
adipocytes, which is independent of HIF-1α, is a mechanism for
reducing oxidative stress resulting from high intracellular lactate
levels (85).
There are, of course, an increasing number of agents which
have been reported to stimulate “browning” (89), but lactate is
of particular interest because of its direct physiological relevance.
WAT is an important site of lactate production and the levels in
the tissue are increased in obesity (5, 90). A model can be pro-
posed in which lactate production rises in WAT in obesity in
response to developing hypoxia as large adipocytes switch from
aerobic to anaerobic metabolism (Figure 2). The lactate then stim-
ulates Ucp1 expression in neighboring white adipocytes, through
an autocrine/paracrine action, leading to the recruitment of brite
cells and the emergence of the“browning”phenotype in WAT. This
could reflect a counter-regulatory response with the accumula-
tion of large adipocytes resulting, via a hypoxia-induced elevation
in lactate, in the production of thermogenic cells, which would
oxidize lipid. However, the extent to which brite adipocytes may
contribute to thermogenesis is debatable, with an extensive vascu-
larization being one of the factors required for clusters of brite cells
to make a significant contribution to adaptive heat production.
CODA
The effects of hypoxia on white adipocytes are extensive, rang-
ing from the stimulation of the production of adipokines linked
to inflammation to the induction of insulin resistance. Hypoxia
also occurs in BAT in obesity, compromising thermogenic activity
and potentially the role of the tissue in metabolic homeostasis.
Mitochondrial loss and dysfunction, insulin resistance, fibrosis,
increased glucose uptake, and lactate production may all occur in
BAT following hypoxia, paralleling many of the changes in WAT
induced by low pO2. Hypoxia-induced increases in lactate pro-
duction by white adipocytes in obese WAT provides a signal for
the induction of browning such that Ucp1 is expressed and brite
fat cells recruited.
It is suggested that reduced O2 tension may be a critical
influence on all forms of adipose tissue in obesity, profoundly
FIGURE 2 | Model of how hypoxia may lead to the recruitment of brite adipocytes and the “browning” of white adipose tissue depots through
stimulating the production and release of lactate. FA, fatty acid; UCP1, uncoupling protein-1.
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altering the function of classical white and brown adipocytes and
stimulating the development of brite fat cells.
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